ADORA2A and Parkinson disease: Based on these findings, our group proposed that the bladder overactivity associated with PD is at least in part induced by the enhanced activity of the adenosine A2A receptors in the brain, while the dopamine D1 receptor mediated inhibition of bladder overactivity involves the suppression of the A2A receptor activation in PD patients (Figure 3).